ID   RHG07_RAT               Reviewed;        1091 AA.
AC   Q63744;
DT   15-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   15-NOV-2002, sequence version 3.
DT   02-OCT-2024, entry version 156.
DE   RecName: Full=Rho GTPase-activating protein 7;
DE   AltName: Full=Deleted in liver cancer 1 protein homolog;
DE            Short=DLC-1;
DE   AltName: Full=Rho-type GTPase-activating protein 7;
DE   AltName: Full=START domain-containing protein 12;
DE            Short=StARD12;
DE   AltName: Full=StAR-related lipid transfer protein 12;
DE   AltName: Full=p122-RhoGAP;
GN   Name=Dlc1; Synonyms=Arhgap7, Rhogap, Stard12;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7835339; DOI=10.1002/j.1460-2075.1995.tb07002.x;
RA   Homma Y., Emori Y.;
RT   "A dual functional signal mediator showing RhoGAP and phospholipase C-delta
RT   stimulating activities.";
RL   EMBO J. 14:286-291(1995).
RN   [2]
RP   FUNCTION, AND MUTAGENESIS OF ARG-677; LYS-714; ARG-718 AND ASN-787.
RX   PubMed=10364218; DOI=10.1074/jbc.274.25.17757;
RA   Sekimata M., Kabuyama Y., Emori Y., Homma Y.;
RT   "Morphological changes and detachment of adherent cells induced by p122, a
RT   GTPase-activating protein for Rho.";
RL   J. Biol. Chem. 274:17757-17762(1999).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Functions as a GTPase-activating protein for the small
CC       GTPases RHOA, RHOB, RHOC and CDC42, terminating their downstream
CC       signaling. This induces morphological changes and detachment through
CC       cytoskeletal reorganization, playing a critical role in biological
CC       processes such as cell migration and proliferation. Also functions in
CC       vivo as an activator of the phospholipase PLCD1. Active DLC1 increases
CC       cell migration velocity but reduces directionality (By similarity).
CC       Required for growth factor-induced epithelial cell migration; in
CC       resting cells, interacts with TNS3 while PTEN interacts with the p85
CC       regulatory subunit of the PI3K kinase complex but growth factor
CC       stimulation induces phosphorylation of TNS3 and PTEN, causing them to
CC       change their binding preference so that PTEN interacts with DLC1 and
CC       TNS3 interacts with p85 (By similarity). The PTEN-DLC1 complex
CC       translocates to the posterior of migrating cells to activate RHOA while
CC       the TNS3-p85 complex translocates to the leading edge of migrating
CC       cells to promote RAC1 activation (By similarity).
CC       {ECO:0000250|UniProtKB:Q96QB1, ECO:0000269|PubMed:10364218}.
CC   -!- SUBUNIT: Interacts with EF1A1, facilitates EF1A1 distribution to the
CC       membrane periphery and ruffles upon growth factor stimulation and
CC       suppresses cell migration. Interacts with tensin TNS1 (via N-terminus);
CC       the interaction is decreased by phosphorylation of TNS1. Interacts with
CC       TNS3 and PTEN; in resting cells, interacts with TNS3 (via C2 tensin-
CC       type domain) but, following growth factor stimulation, TNS3 and PTEN
CC       are phosphorylated which leads to weakened interaction with TNS3 and
CC       enhanced interaction with PTEN. Interacts (via C-terminus) with tensin
CC       TNS4 (via SH2 domain); the interaction is independent of tyrosine
CC       phosphorylation of DLC1. {ECO:0000250|UniProtKB:Q96QB1}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, focal
CC       adhesion {ECO:0000250|UniProtKB:Q96QB1}. Membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Note=Colocalizes with EF1A1
CC       at actin-rich regions in the cell periphery. {ECO:0000250}.
CC   -!- DOMAIN: The SAM domain mediates interaction with EF1A1, and functions
CC       as an autoinhibitory regulator of RhoGAP Activity. {ECO:0000250}.
CC   -!- DOMAIN: The polybasic cluster is required for activation and mediates
CC       binding to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P(2))
CC       containing membranes. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA21675.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D31962; BAA21675.1; ALT_INIT; mRNA.
DR   AlphaFoldDB; Q63744; -.
DR   SMR; Q63744; -.
DR   STRING; 10116.ENSRNOP00000075006; -.
DR   iPTMnet; Q63744; -.
DR   PhosphoSitePlus; Q63744; -.
DR   PaxDb; 10116-ENSRNOP00000014923; -.
DR   AGR; RGD:68416; -.
DR   RGD; 68416; Dlc1.
DR   eggNOG; KOG2200; Eukaryota.
DR   InParanoid; Q63744; -.
DR   PhylomeDB; Q63744; -.
DR   Reactome; R-RNO-8980692; RHOA GTPase cycle.
DR   Reactome; R-RNO-9013026; RHOB GTPase cycle.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   PRO; PR:Q63744; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005884; C:actin filament; IDA:RGD.
DR   GO; GO:0005901; C:caveola; ISO:RGD.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032587; C:ruffle membrane; ISO:RGD.
DR   GO; GO:0001725; C:stress fiber; IDA:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:RGD.
DR   GO; GO:0008289; F:lipid binding; IEA:InterPro.
DR   GO; GO:0043274; F:phospholipase binding; IPI:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0017166; F:vinculin binding; IPI:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0007010; P:cytoskeleton organization; IDA:RGD.
DR   GO; GO:0048041; P:focal adhesion assembly; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0003007; P:heart morphogenesis; ISO:RGD.
DR   GO; GO:0021575; P:hindbrain morphogenesis; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0051895; P:negative regulation of focal adhesion assembly; ISO:RGD.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; ISO:RGD.
DR   GO; GO:0051497; P:negative regulation of stress fiber assembly; ISO:RGD.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; ISO:RGD.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; ISO:RGD.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd04375; RhoGAP_DLC1; 1.
DR   CDD; cd09591; SAM_DLC1; 1.
DR   Gene3D; 1.10.287.2070; -; 1.
DR   Gene3D; 3.30.530.20; -; 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR023393; START-like_dom_sf.
DR   InterPro; IPR002913; START_lipid-bd_dom.
DR   PANTHER; PTHR12659:SF2; RHO GTPASE-ACTIVATING PROTEIN 7; 1.
DR   PANTHER; PTHR12659; RHO-TYPE GTPASE ACTIVATING PROTEIN; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   Pfam; PF01852; START; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00234; START; 1.
DR   SUPFAM; SSF55961; Bet v1-like; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50848; START; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cytoplasm; GTPase activation; Membrane; Phosphoprotein;
KW   Reference proteome; Tumor suppressor.
FT   CHAIN           1..1091
FT                   /note="Rho GTPase-activating protein 7"
FT                   /id="PRO_0000056709"
FT   DOMAIN          11..78
FT                   /note="SAM"
FT   DOMAIN          641..847
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   DOMAIN          877..1084
FT                   /note="START"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00197"
FT   REGION          119..181
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          274..447
FT                   /note="Focal adhesion-targeting (FAT)"
FT                   /evidence="ECO:0000250"
FT   REGION          296..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          402..439
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          491..552
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          614..636
FT                   /note="Polybasic cluster (PBR)"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        126..181
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QB1"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QB1"
FT   MOD_RES         129
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QB1"
FT   MUTAGEN         677
FT                   /note="R->E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10364218"
FT   MUTAGEN         714
FT                   /note="K->E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10364218"
FT   MUTAGEN         718
FT                   /note="R->E: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10364218"
FT   MUTAGEN         787
FT                   /note="N->V: No loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10364218"
SQ   SEQUENCE   1091 AA;  123414 MW;  FB4A0924E0C36A15 CRC64;
     MCRDEPDTMI LTQIEAKEAC DWLRVTGFPQ YAQLYEDLLF PIDIALVKRE HDFLDRDAIE
     ALCRRLNTLN KCAVMKLEIS PHRKRSEDSD EEEPCAISGK WTFQRDSKRW SRLEEFDVFS
     PKQDPIPGSP DNSRLQSATS RESMLTDLSE HQEVSSIRSL SSTSSSAPTH VPHSGEATTP
     RTNSVISVCS SSHFVGNEDS FSSLPSPKEL SSFSFSMKGH EKNTKSKTRS LLKRMESLKL
     KGSHHSKHKA PSKLGLIISA PILQEGMDEE KLKQLNCVEI SALNGNHINV PMVRKRSVSN
     STQTSSSSSQ SETSSAVSTP SPVTRTRSLS TCNKRVGMYL EGFDPFSQSA FNNVTEQNYK
     NRESYPEDTV FYIPEDHKPG TFPKALSNGS FCPSGNSSVN WRTGSFHGPG HLSLRRENSS
     DSPKELKRRN SSSSVSSRMS IYDNVPGSIL YSSSGELADL ENEDIFPELD DILYHVKGMQ
     RIVNQWSEKF SDEGDSDSAL DSVSPCPSSP KQIHLDVDHD RRTPSDLDST GNSLNEPEEP
     TDIPERRDSG VGASLTRCNR HRLRWHSFQS SHRPSLNSVS LQINCQSVAQ MNLLQKYSLL
     KLTALLEKYT PSNKHGFSWA VPKFMKRIKV PDYKDRSVFG VPLTVNVQRS GQPLPQSIQQ
     AMRYLRNHCL DQVGLFRKSG VKSRIQALRQ MNESAEDYVN YEGQSAYDVA DMLKQYFRDL
     PEPLMTNKLS ETFLQIYQYV PKDQRLQAIK AAIMLLPDEN REVLQTLLYF LSHVTAAVKE
     NQMTPTNLAV CLAPSLFHLN TLKRENSSPR VMQRKQSLGK PDQKDLNENL AATQGLAHMI
     AECKKLFQVP EEMSRCRNSY TEQELKPLTL EALGHLSNDQ PADYRHFLQD CVDGLFKEVK
     EKFKGWVSYP TSEQAELSYK KVSEGPPLRL WRATIEVPAA PEEILKRLLK EQHLWDVDLL
     DSKVIEILDS QTEIYQYVQN SMAPHPARDY VVLRTWRTNL PRGACALLFT SVDHDRAPVA
     GVRVNVLLSR YLIEPCGSGK SKLTYMCRAD LRGHMPEWYT KSFGHLCAAE VVKIRDSFSN
     QSTESKDTRS R
//
